Navigation and service

You are here:PRAC

PRAC

Pharmacovigilance Risk Assessment Committee

The Pharmacovigilance Risk Assessment Committee (PRAC) is the European Medicines Agency's committee responsible for monitoring and assessing safety issues for human medicines.
The Pharmacovigilance Risk Assessment Committee consists of scientific experts from all Member States of the EEA; for further information on the Pharmacovigilance Risk Assessment Committee (PRAC) please visit the European Medicines Agency's website.